|
Now Accepting Applications for
Aspire Summer Programs!
|
Adventure Camp: Making Sense of the '3S' Model
|
By Elise Wulff, M.Ed. 
With another summer just around the corner, we're busy planning programs that will offer a fun, engaging, and productive experience for both our campers and our staff. We're often asked, "What is the secret to the Aspire Model?" While there are many key ingredients, one of our greatest assets is our staff. Our staff comes to us from a variety of backgrounds in the health and human services and education fields (OTs, SLPs, Special Education teachers, Social Workers, among others).
[Read More]
|
Child Summer Camp Open House!
|
Explore
our Hale Site | Meet Staff | Learn More
Aspire has made some exciting changes to our summer camp program.
This event is an opportunity speak with summer staff and to tour our favorite Hale sites including our beautiful new Simches Pavilion.
This will be a kid-friendly event for anyone curious to learn more.
Providers, parents, campers, potential campers, siblings - all are all welcome!
Sunday, May 7th
Hale Reservation, Westwood, MA
Pre-registration for this event is
required by:
Monday May 1st
|
New! Second Explorations Location!
|
The teen Explorations program is expanding to another site - Charlestown!
The program will be run in two separate locations:
Summer Explorations Program in Charlestown:
Dates: Wednesday, July 5th - Friday, August 11th
Days: Monday-Friday
Time: 9:30 am-3:30 pm
Address:
15 Green St., Charlestown, MA 02129
To learn more about the Teen programs, visit our website.
|
Young Adult Relationship Group
|
Theme:
relationships (intimate and non-intimate); themes can be generated from specific interests of the group members, but can include:
- What can the development of a non-intimate relationship look like?
- What can the development of an intimate relationship look like?
- What are some ways to work through differences and challenges in intimate and non-intimate relationships (e.g., different political beliefs)?
Clinician: Scott McLeod, Ph.D
Dates: June 29 - August 10
Day: Thursday
Time: 6:00 - 7:30 pm
Location: Lexington
Duration: 7 weeks
|
|
|
Lurie Center for Autism
The Lurie Center for Autism at Massachusetts General Hospital for Children is looking for participants for their currently enrolling studies! For additional information about study requirements and study procedures, please contact Dr. Christopher McDougle's or
Dr. Ann Neumeyer's
study staff at 781-860-1711 or
LurieCenterResearch@partners.org
.
- Children's Autism Metabolome Project (CAMP) - The Lurie Center is enrolling children ages 18 to 48 months who are in the process of getting evaluated for an autism spectrum disorder or developmental disorder, as well as typically developing children. This research study is being conducted to find out if a specific blood test is effective in the early detection of autism spectrum disorder. Participants are compensated for their time.
- Mirtazapine Treatment of Anxiety in Autism - The Lurie Center is conducting a study designed to evaluate the effects of mirtazapine in children with autistic disorder, Asperger's disorder or PDD not otherwise specified. Participants must be between the ages of 5 and 17 with difficulties with anxiety. Participants must have no significant medical illness and not have had a previous adequate trial of mirtazapine. Participants will receive study medication and all study related evaluations at no charge.
- Investigation of Neuroinflammation in Autism - Seeking men aged 18-40 years with and without autism to participate in an investigation of the structure and function of the brain of adults with and without autism using MR-PET scans. Participants are compensated for their time.
The Bressler Clinical and Research Center
-
ASD Namenda Study Taking Place at MGH -
This 12-week study seeks to evaluate the safety and efficacy of Namenda (memantine) for the treatment of core features of Autism Spectrum Disorder (ASD) in children and adolescents. Deficits in social interaction are the central feature of ASD and often result in significant impairment for individuals with High Functioning-ASD. Available data from past treatment studies of Namenda demonstrates improvements in a range of impairments including attentional and social skills in individuals with ASD. Eligible subjects, children ages 8-17 with a DSM-V diagnosis of ASD, will be enrolled to receive either placebo or Namenda. Subjects also complete a pre- and post-treatment brain scan before and after treatment with Namenda.
To learn more, contact Abigail Belser :781-724-7079 | abelser@partners.org
|
|
| |
|
Apply
for the
Internship Program!
|
| About Aspire
Aspire is dedicated to providing children, teens, and adults with a high cognitive autism spectrum disorder or a related profile with the knowledge and skills necessary to make social connections and develop independence leading to successful and fulfilling lives.
MGH Aspire
1 Maguire Road
Lexington, MA 02421
p:781-860-1900
f: 781-860-1920
|
|
|
